Table 1.
Study | Location | Communities | Individuals (baseline) | Fraction younger than 1 year (%) | Reported coverage (%) |
---|---|---|---|---|---|
MORDOR | Niger | 594 | 76,490 | 9.3 | 92–98 |
PRET | Niger | 48 | 13,488 | 10.9 | 79–96 |
MORDOR | Tanzania | 614 | 35,226 | 6.2 | 80–91 |
MORDOR | Malawi | 304 | 78,920 | 6.7 | 88–95 |
TANA | Ethiopia | 48 | 9,754 | 0 | 81–89 |
MORDOR = Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance; PRET = Rapid Elimination of Trachoma; TANA = Trachoma Amelioration in Northern Amhara. The number of randomization units is given in the Communities column. In the TANA study, individuals younger than 1 year were not treated. Full details are provided elsewhere.1,2,4